SCHEMBL4711247

SCHEMBL4711247

Cc1ccc(C=Cc2cccc(C)n2)cc1

nearest known ligand 0.76

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.76
ALDH1A1 P00352 3/20 0.76
NPC1 O15118 3/20 0.76
RAB9A P51151 3/20 0.76
GRM4 Q14833 3/20 0.76
SMN1; SMN2 Q16637 3/20 0.76
HPGD P15428 3/20 0.76
CYP2C9 P11712 2/20 0.76
CYP2C19 P33261 2/20 0.76
MEN1 O00255 2/20 0.76
PKM P14618 2/20 0.76
NFKB1 P19838 2/20 0.76
KMT2A Q03164 2/20 0.76
GRM5 P41594 1/20 0.76
NPSR1 Q6W5P4 1/20 0.76
HDAC6 Q9UBN7 1/20 0.76
CYP3A4 P08684 1/20 0.76
CYP2D6 P10635 1/20 0.76
TSHR P16473 1/20 0.76
THPO P40225 1/20 0.76

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4711246 1.00 KDM4E (0.76) KDM4EALDH1A1NPC1RAB9AGRM4
SCHEMBL29510104 0.86 GRM4 (1.00) KDM4EALDH1A1NPC1RAB9AGRM4
SCHEMBL350949 0.86 GRM4 (1.00) KDM4EALDH1A1NPC1RAB9AGRM4
SCHEMBL179801 0.86 GRM4 (1.00) KDM4EALDH1A1NPC1RAB9AGRM4
SCHEMBL4712658 0.85 RAB9A (0.76) KDM4EALDH1A1NPC1RAB9AGRM4
SCHEMBL4711083 0.85 ALDH1A1 (0.71) KDM4EALDH1A1NPC1RAB9AGRM4
SCHEMBL4711084 0.85 ALDH1A1 (0.71) KDM4EALDH1A1NPC1RAB9AGRM4
SCHEMBL4710048 0.85 ALDH1A1 (0.71) KDM4EALDH1A1NPC1RAB9AGRM4
SCHEMBL4712696 0.85 NPC1 (0.71) KDM4EALDH1A1NPC1RAB9AGRM4
SCHEMBL4710051 0.85 ALDH1A1 (0.71) KDM4EALDH1A1NPC1RAB9AGRM4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0998459-B1 PYRIDINE DERIVATIVES NOVARTIS AG (CH) 2008-04-23 EP claimed
EP-0998459-A2 PYRIDINE DERIVATIVES Novartis AG (CH) 2000-05-10 EP claimed
WO-1999002497-A2 PYRIDINE DERIVATIVES NOVARTIS AG (CH) 1999-01-21 WO claimed
EP-0998459-B1 PYRIDINE DERIVATIVES NOVARTIS AG (CH) 2008-04-23 EP disclosed
US-6656957-B1 Marked and selective modulating, especially antagonistic, action at human metabotropic glutamate receptors (mGluRs); treatment of disorders such as epilepsy, cerebral ischemias, especially acute ischemias, spasticity etc. NOVARTIS AG (CH) 2003-12-02 US disclosed